Conditions: Overactive Bladder
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 106
Healthy volunteers: no

Brief summary:
The purpose of the trial is to investigate the efficacy of combining tolterodine and desmopressin compared with tolterodine monotherapy in the treatment of women with overactive bladder with nocturia in terms of reduction of nocturnal voids during 3 months of treatment

Detailed description:

Arms:
arm 1: Tolterodine tartrate extended release capsules + Desmopressin orally disintegrating tablets arm 2: Tolterodine tartrate extended release capsules + Placebo orally disintegrating tablets

Interventions: intervention 1: Tolterodine tartrate extended release capsules intervention 2: Desmopressin orally disintegrating tablets intervention 3: Placebo orally disintegrating tablets
Intervention descriptions: intervention 1: None intervention 2: None intervention 3: None

Protocol document: